Intech Biopharm
Highly Engaged Employees
Manufacturing · Taiwan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3f No.36 Ln. 358 Ruiguang Rd, Dist., Tai...Phone Number
+886 277218800Website
www.intechbiopharm.comRevenue
$5.2 MillionIndustry
About Intech Biopharm
Intech Biopharm Org Chart
Is Intech Biopharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Intech Biopharm launches new products
Website visits: Recent activity has been detected on your website
Check if Intech Biopharm has recently received funding, and reach out quickly before it becomes old news!
Intech Biopharm, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Intech Biopharm is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Intech Biopharm has new funding data
Click to see if Intech Biopharm had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Intech Biopharm
Earning: See what the market has to say on Intech Biopharm recently announced quarterly report
Recommended Actions
Find VP level buyers at Intech Biopharm
Find more new buyers
Company Profile Activity
Activity Insights
Intech Biopharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Intech Biopharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Intech Biopharm.
Intech Biopharm Tech Stack
A closer look at the technologies used by Intech Biopharm
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Intech Biopharm
Intech Biopharm currently focuses mainly on developing drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease (COPD). By owning the superior HFA MDI platforms with facilities at the high level as EMA and US FDA standard, we have received a number of governmental grants and awards, and moreover, impo... Read More